title: Injection sclerotherapy for esophageal varices caused by schistosomal hepatic fibrosis.
abstract: Sixty patients with esophageal varices caused by schistosomal hepatic fibrosis were managed by injection sclerotherapy. Bleeding was controlled in 17 of 20 patients (85%) with acute bleeding from varices. The remaining 40 patients were either unfit for operation or had a recurrence of variceal bleeding after operation. In a period of follow-up that ranged from 14 to 31 months (mean 18.4 months), 11 patients (18.3%) had a recurrence of bleeding that was controlled and four patients (6.7%) had a fatal recurrence of bleeding. The overall mortality rate was 25% (15 patients), and 34 patients (56.7%) had no recurrence of bleeding.
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000628:therapy; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012552:Schistosomiasis / Q000150:complications / Q000628:therapy*; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D012597:Sclerosing Solutions